Production, purification, and capsid stability of rhinovirus C types

Journal of Virological Methods

Volumn 217, Issue , 2015, Pages 18-23

  Griggs, Theodor F ^a,b   Bochkov, Yury A ^a   Nakagome, Kazuyuki ^a   Palmenberg, Ann C ^b   Gern, James E ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Centrifugation; Concentration; Purification; Rhinovirus C; Stability

Indexed keywords

DETERGENT; SUCROSE; VIRUS RNA;

ACIDITY; ANALYTIC METHOD; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LUNG ALVEOLUS EPITHELIUM CELL; LUNG FIBROBLAST; MILK; MOLECULAR STABILITY; NONHUMAN; OSMOTIC STRESS; PH; PRIORITY JOURNAL; RHINOVIRUS; RHINOVIRUS TYPE C; RNA ANALYSIS; STANDARD; SUSPENSION CELL CULTURE; TEMPERATURE STRESS; VIRION; VIROGENESIS; VIRUS CAPSID; VIRUS CULTURE; VIRUS ISOLATION; VIRUS PURIFICATION; VIRUS VIRULENCE; DRUG EFFECTS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL VIABILITY; OSMOTIC PRESSURE; PHYSIOLOGY; PROCEDURES; RADIATION RESPONSE; TEMPERATURE; VIROLOGY;

MIRIDAE; RHINOVIRUS;

CAPSID; DETERGENTS; HYDROGEN-ION CONCENTRATION; MICROBIAL VIABILITY; OSMOTIC PRESSURE; RHINOVIRUS; TEMPERATURE; VIROLOGY;

EID: 84924587621     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2015.02.019     Document Type: Article

References (30)

1. Arden K.E., McErlean P., Nissen M.D., Sloots T.P., Mackay I.M. Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J. Med. Virol. 2006, 78:1232-1240. 10.1002/jmv.20689.
2. Ashraf S., Brockman-Schneider R., Bochkov Y.A., Pasic T.R., Gern J.E. Biological characteristics and propagation of human rhinovirus-C in differentiated sinus epithelial cells. Virology 2013, 436:143-149. 10.1016/j.virol.2012.11.002.
3. Basta H.A., Sgro J.-Y., Palmenberg A.C. Modeling of the human rhinovirus C capsid suggests a novel topography with insights on receptor preference and immunogenicity. Virology 2014, 448:176-184. 10.1016/j.virol.2013.10.006.
4. Behbehani A.M., Lee L.H. Growth, plaque production, and cationic stabilization of rhinovirus type 1 (echovirus 28). J. Bacteriol. 1964, 88:1608-1611.
5. Bochkov Y.A., Palmenberg A.C., Lee W.-M., Rathe J.A., Amineva S.P., Sun X., Pasic T.R., Jarjour N.N., Liggett S.B., Gern J.E. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat. Med. 2011, 17:627-632. 10.1038/nm.2358.
6. Brownlee J.W., Turner R.B. New developments in the epidemiology and clinical spectrum of rhinovirus infections. Curr. Opin. Pediatr. 2008, 20:67-71. 10.1097/MOP.0b013e3282f41cb6.
7. Cox D.W., Bizzintino J., Ferrari G., Khoo S.K., Zhang G., Whelan S., Lee W.M., Bochkov Y.A., Geelhoed G.C., Goldblatt J., Gern J.E., Laing I.A., Le Souëf P.N. Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions. Am. J. Respir. Crit. Care Med. 2013, 188:1358-1364. 10.1164/rccm201303-0498OC.
8. Dorval B.L., Chow M., Klibanov A.M. Stabilization of poliovirus against heat inactivation. Biochem. Biophys. Res. Commun. 1989, 159:1177-1183.
9. Gassilloud B., Gantzer C. Adhesion-aggregation and inactivation of poliovirus 1 in groundwater stored in a hydrophobic container. Appl. Environ. Microbiol. 2005, 71:912-920. 10.1128/AEM.71.2.912-920.2005.
10. Gern J.E. The ABCs of rhinoviruses, wheezing, and asthma. J. Virol. 2010, 84:7418-7426. 10.1128/JVI02290-09.
11. Hao W., Bernard K., Patel N., Ulbrandt N., Feng H., Svabek C., Wilson S., Stracener C., Wang K., Suzich J., Blair W., Zhu Q. Infection and propagation of human rhinovirus C in human airway epithelial cells. J. Virol. 2012, 86:13524-13532. 10.1128/JVI02094-12.
12. Lamson D., Renwick N., Kapoor V., Liu Z., Palacios G., Ju J., Dean A., St George K., Briese T., Lipkin W.I. MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005. J. Infect. Dis. 2006, 194:1398-1402. 10.1086/508551.
13. Lee W.M., Monroe S.S., Rueckert R.R. Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J. Virol. 1993, 67:2110-2122.
14. Lee W.M., Wang W., Rueckert R.R. Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group. Virus Genes 1995, 9:177-181.
15. Lee W.-M., Lemanske R.F., Evans M.D., Vang F., Pappas T., Gangnon R., Jackson D.J., Gern J.E. Human rhinovirus species and season of infection determine illness severity. Am. J. Respir. Crit. Care Med. 2012, 186:886-891. 10.1164/rccm.201202-0330OC.
16. Miller E.K., Lu X., Erdman D.D., Poehling K.A., Zhu Y., Griffin M.R., Hartert T.V., Anderson L.J., Weinberg G.A., Hall C.B., Iwane M.K., Edwards K.M., New Vaccine Surveillance Network Rhinovirus-associated hospitalizations in young children. J. Infect. Dis. 2007, 195:773-781. 10.1086/511821.
17. Milo G.E. Thermal inactivation of poliovirus in the presence of selective organic molecules (cholesterol, lecithin, collagen, and beta-carotene). Appl. Microbiol. 1971, 21:198-202.
18. Nakagome K., Bochkov Y.A., Ashraf S., Brockman-Schneider R.A., Evans M.D., Pasic T.R., Gern J.E. Effects of rhinovirus species on viral replication and cytokine production. J. Allergy Clin. Immunol. 2014, 134:332-341. 10.1016/j.jaci.2014.01.029.
19. Pande J., Szewczyk M.M., Grover A.K. Phage display: concept, innovations, applications and future. Biotechnol. Adv. 2010, 28:849-858. 10.1016/j.biotechadv.2010.07.004.
20. Peltola V., Waris M., Osterback R., Susi P., Ruuskanen O., Hyypiä T. Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J. Infect. Dis. 2008, 197:382-389. 10.1086/525542.
21. Price W.H. The isolation of a new virus associated with respiratory clinical disease in humans. Proc. Natl. Acad. Sci. U.S.A. 1956, 42:892-896.
22. 2+ of the neutralization epitopes of poliovirus. J. Gen. Virol. 1985, 66(Pt 2):303-307.
23. Rossmann M.G. Structure of viruses: a short history. Q. Rev. Biophys. 2013, 46:133-180. 10.1017/S0033583513000012.
24. Rueckert R.R., Pallansch M.A. Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol. 1981, 78:315-325.
25. Savolainen-Kopra C., Korpela T., Simonen-Tikka M.-L., Amiryousefi A., Ziegler T., Roivainen M., Hovi T. Single treatment with ethanol hand rub is ineffective against human rhinovirus--hand washing with soap and water removes the virus efficiently. J. Med. Virol. 2012, 84:543-547. 10.1002/jmv.23222.
26. Sherry B., Rueckert R. Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J. Virol. 1985, 53:137-143.
27. Sherry B., Mosser A.G., Colonno R.J., Rueckert R.R. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J. Virol. 1986, 57:246-257.
28. Tomasula P.M., Kozempel M.F., Konstance R.P., Gregg D., Boettcher S., Baxt B., Rodriguez L.L. Thermal inactivation of foot-and-mouth disease virus in milk using high-temperature, short-time pasteurization. J. Dairy Sci. 2007, 90:3202-3211. 10.3168/jds.2006-525.
29. Wang W., Lee W.M., Mosser A.G., Rueckert R.R. WIN 52035-dependent human rhinovirus 16: assembly deficiency caused by mutations near the canyon surface. J. Virol. 1998, 72:1210-1218.
30. Watters K., Palmenberg A.C. Differential processing of nuclear pore complex proteins by rhinovirus 2A proteases from different species and serotypes. J. Virol. 2011, 85:10874-10883. 10.1128/JVI.00718-11.